6-aminonicotinamide has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funami, H; Kanki, S; Koyama, M; Maruoka, H; Muto, T; Shibata, M; Takahashi, B | 1 |
| Floyd, BC; George, S; Gupte, RS; Gupte, SA; Kozicky, M; Neito, V; Ungvari, ZI; Wolin, MS | 1 |
2 other study(ies) available for 6-aminonicotinamide and Obesity
| Article | Year |
|---|---|
Structural Optimization of Ghrelin Receptor Inverse Agonists to Improve Lipophilicity and Avoid Mechanism-Based CYP3A4 Inactivation.
Topics: 6-Aminonicotinamide; Anti-Obesity Agents; Cytochrome P-450 CYP3A; Drug Discovery; Drug Inverse Agonism; Humans; Microsomes, Liver; Obesity; Receptors, Ghrelin | 2015 |
Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver.
Topics: 6-Aminonicotinamide; Animals; Cell Extracts; Cells, Cultured; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gluconates; Glucosephosphate Dehydrogenase; Glycoproteins; Liver; Male; NADPH Oxidases; Obesity; Pentose Phosphate Pathway; Perfusion; Phosphatidylinositol 3-Kinases; Rats; Rats, Zucker; Signal Transduction; src-Family Kinases; Superoxides; Up-Regulation | 2009 |